A Study of Ward Admissions for Haematuria
Recruiting
Observational Study
Urologic Diseases
Hematuria
Hematuria; Benign
Bladder Cancer
Renal Cancer
Urothelial Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,050 (estimated)
- Sponsor
- British Urology Researchers in Surgical Training · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multicenter, prospective observational study will evaluate national and international practice variations (if present) in the emergency management of patients admitted to hospital with haematuria, inform a consensus guideline for best practice and provide evidence to design an implementation study to optimise haematuria management pathway.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients are included if they are over 16 years of age or older and admitted to a participating urological secondary care centre
* admitted as an emergency with haematuria as the primary or secondary diagnosis under the primary or joint care of urology
Exclusion Criteria:
* …
Contacts